Bacterial 30S ribosomal subunit and UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA) (30S + MurA)

The 30S ribosomal subunit is a critical component of the bacterial 70S ribosome, serving as the site for mRNA decoding and the initiation of protein translation (Wikipedia, 2024). UDP-N-acetylglucosamine 1-carboxyvinyltransferase, or MurA, is a cytoplasmic enzyme that catalyzes the first committed step in the biosynthesis of peptidoglycan, which is the primary structural component of the bacterial cell wall (UniProt, 2024). Both the 30S subunit and MurA are essential for bacterial survival and are well-established targets for antimicrobial therapy (NIH, 2023). Antibiotics such as aminoglycosides and tetracyclines exert their effects by binding to the 30S subunit, leading to mistranslation or inhibition of protein synthesis (StatPearls, 2023). In contrast, the antibiotic fosfomycin acts as a structural analogue of phosphoenolpyruvate to covalently inhibit MurA, thereby blocking cell wall assembly (PubChem, 2024). While both are vital for bacterial life, they operate in distinct metabolic pathways and are not part of the same physical complex. Consequently, this entry represents a composite of two separate therapeutic targets rather than a single molecular entity (PubMed, 2022). Targeting these pathways is fundamental in treating a wide range of bacterial infections, although resistance mechanisms against both targets are increasingly prevalent in clinical settings (StatPearls, 2023).

Other names

30S ribosomeUDP-N-acetylglucosamine 1-carboxyvinyltransferaseMurAEnolpyruvyl transferaseSmall ribosomal subunit

Inhibition of the 30S ribosomal subunit disrupts bacterial protein synthesis by interfering with mRNA decoding and tRNA binding (StatPearls, 2023). Inhibition of MurA blocks the conversion of UDP-N-acetylglucosamine to UDP-N-acetylenolpyruvylglucosamine, preventing the formation of the bacterial cell wall (PubChem, 2024).